Indian Drugmaker Taps Private Credit for Japanese Acquisition

Indian drugmaker Gujarat Themis Biosyn Ltd. has obtained private credit funding to back its purchase of Japanese peer MicroBiopharm Japan Co., highlighting the growing use of such debt for overseas expansion in Asia.

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.